# OnCo record c-ray-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/c-ray-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "c-ray-therapeutics" ;
  schema:name "C Ray Therapeutics"@en ;
  schema:alternateName "C-Ray"@en, "C Ray Therapeutics (Chengdu) Co., Ltd."@en ;
  schema:description "C Ray Therapeutics makes radioactive medicines and also manufactures them for other companies. Its own lead treatment, TRC003, carries a radioactive atom to prostate cancer cells and is in an early trial for advanced prostate cancer that no longer responds to hormone treatment."@en ;
  schema:url <https://onco.cc/companies/c-ray-therapeutics/>, <https://www.c-raytherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.c-raytherapeutics.com/>, <https://navigator.reaganudall.org/c-ray-therapeutics-chengdu-co-ltd>, <https://clinicaltrials.gov/study/NCT07567521>, <https://clinicaltrials.gov/study/NCT07236112> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/radiopharmaceutical-gmp-release/> ;
  onco:targets <https://onco.cc/targets/psma/> ;
  onco:trials <https://onco.cc/trials/nct07567521/> .